BioCatalystWatch
IMMXWorkspace / IMMX / OverviewCompany library
Immix Biopharma, Inc. logo

Immix Biopharma, Inc.

Immix Biopharma, Inc. (IMMX)

Website

Price
Market cap
Next catalystDec 14, 2026NXC-201 — NEXICART-2 · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

NXC-201

BCMA

PreINDP1P2FilingApproved
Upcoming / outlook

NXC-201

BCMA

Upcoming / outlook

NXC-201

BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

NXC-201

BCMA

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

NXC-201

BCMA

PreINDP1P2FilingApproved
Upcoming / outlook

NXC-201

BCMA

Upcoming / outlook

Other pipelines

NXC-201

BCMA

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status
3M

Market Reaction / Supply Context

Market Structure

IMMX PR & News

PR & News

IMMX SEC archive